Incidental Mutation 'IGL03268:Acvrl1'
ID 415167
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Acvrl1
Ensembl Gene ENSMUSG00000000530
Gene Name activin A receptor, type II-like 1
Synonyms activin receptor-like kinase-1, Alk-1, Acvrlk1, Alk1
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # IGL03268
Quality Score
Status
Chromosome 15
Chromosomal Location 101026403-101043217 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to T at 101033803 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Isoleucine to Phenylalanine at position 162 (I162F)
Ref Sequence ENSEMBL: ENSMUSP00000114027 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000000542] [ENSMUST00000117984] [ENSMUST00000119063] [ENSMUST00000120028] [ENSMUST00000120754] [ENSMUST00000121718] [ENSMUST00000124151] [ENSMUST00000144229] [ENSMUST00000130432]
AlphaFold Q61288
Predicted Effect possibly damaging
Transcript: ENSMUST00000000542
AA Change: I162F

PolyPhen 2 Score 0.480 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000000542
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
Pfam:Activin_recp 31 102 2.1e-10 PFAM
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect possibly damaging
Transcript: ENSMUST00000117984
AA Change: I162F

PolyPhen 2 Score 0.480 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000113505
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
PDB:2LCR|A 19 116 4e-43 PDB
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect possibly damaging
Transcript: ENSMUST00000119063
AA Change: I162F

PolyPhen 2 Score 0.480 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000113536
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
Pfam:Activin_recp 31 102 2.1e-10 PFAM
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect possibly damaging
Transcript: ENSMUST00000120028
AA Change: I162F

PolyPhen 2 Score 0.480 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000113297
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
Pfam:Activin_recp 31 102 2.1e-10 PFAM
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000120754
AA Change: I162F

PolyPhen 2 Score 0.012 (Sensitivity: 0.96; Specificity: 0.78)
SMART Domains Protein: ENSMUSP00000112490
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
Pfam:Activin_recp 31 102 2.1e-10 PFAM
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect possibly damaging
Transcript: ENSMUST00000121718
AA Change: I162F

PolyPhen 2 Score 0.480 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000114027
Gene: ENSMUSG00000000530
AA Change: I162F

DomainStartEndE-ValueType
Pfam:Activin_recp 31 102 2.1e-10 PFAM
low complexity region 118 139 N/A INTRINSIC
GS 171 201 5.72e-14 SMART
Blast:TyrKc 207 478 1e-29 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000124151
SMART Domains Protein: ENSMUSP00000114829
Gene: ENSMUSG00000000530

DomainStartEndE-ValueType
PDB:2LCR|A 19 76 8e-25 PDB
Predicted Effect noncoding transcript
Transcript: ENSMUST00000153253
Predicted Effect noncoding transcript
Transcript: ENSMUST00000128525
Predicted Effect noncoding transcript
Transcript: ENSMUST00000128868
Predicted Effect probably benign
Transcript: ENSMUST00000144229
Predicted Effect probably benign
Transcript: ENSMUST00000130432
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for targeted mutations that inactivate the gene die at midgestation with severe vascular abnormalities, including fusion of major arteries and veins. Mice heterozygous for one targeted mutation provide a suitable model for hereditary hemorrhagic telangiectasia type 2. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 49 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1500002C15Rik G T 4: 155,818,648 (GRCm39) probably benign Het
Adprhl1 A G 8: 13,296,170 (GRCm39) probably benign Het
Anapc7 G A 5: 122,567,669 (GRCm39) probably null Het
Ankrd13a T C 5: 114,930,296 (GRCm39) L227P probably damaging Het
Anxa5 T C 3: 36,504,828 (GRCm39) I245V probably benign Het
Arf1 A T 11: 59,103,663 (GRCm39) V123E possibly damaging Het
Catsperg1 G A 7: 28,899,668 (GRCm39) R338C probably damaging Het
Cc2d1a A C 8: 84,860,154 (GRCm39) L855R probably damaging Het
Cdh18 G A 15: 23,366,953 (GRCm39) A220T probably damaging Het
Cep350 T C 1: 155,829,295 (GRCm39) H203R probably benign Het
Cep78 G T 19: 15,951,806 (GRCm39) S333* probably null Het
Chrna2 T A 14: 66,388,395 (GRCm39) probably benign Het
Dact1 T C 12: 71,364,257 (GRCm39) V346A probably damaging Het
Dcn A G 10: 97,319,240 (GRCm39) I6V probably benign Het
Dlg3 A G X: 99,853,493 (GRCm39) Y600C probably damaging Het
Dmd A G X: 82,849,814 (GRCm39) E1084G probably damaging Het
Epb41 A C 4: 131,655,806 (GRCm39) D825E probably damaging Het
Galc T A 12: 98,188,852 (GRCm39) probably benign Het
Hmcn1 T A 1: 150,648,261 (GRCm39) D675V probably damaging Het
Igkv2-137 A G 6: 67,533,092 (GRCm39) D85G probably benign Het
Kxd1 A G 8: 70,961,136 (GRCm39) I78T probably damaging Het
Lama1 G A 17: 68,111,531 (GRCm39) G2261R probably damaging Het
Lama2 A T 10: 27,298,649 (GRCm39) I149N probably damaging Het
Mbnl2 G T 14: 120,616,569 (GRCm39) C61F probably damaging Het
Mcts1 T C X: 37,690,859 (GRCm39) I22T possibly damaging Het
Or4k15b T C 14: 50,272,024 (GRCm39) T279A probably damaging Het
Or52e3 T G 7: 102,869,848 (GRCm39) F308V probably benign Het
Pde12 T A 14: 26,389,614 (GRCm39) E365V probably benign Het
Prl8a2 A G 13: 27,537,938 (GRCm39) K204R probably benign Het
Rnf25 A T 1: 74,638,217 (GRCm39) probably benign Het
Rragb A G X: 151,923,493 (GRCm39) D5G unknown Het
Rsrc2 T A 5: 123,878,790 (GRCm39) K56* probably null Het
Scn5a T C 9: 119,350,297 (GRCm39) Q859R probably damaging Het
Septin4 G A 11: 87,480,529 (GRCm39) V388M probably damaging Het
Slc29a2 C T 19: 5,074,531 (GRCm39) probably benign Het
Slc30a5 G A 13: 100,943,211 (GRCm39) T549I probably damaging Het
Slc7a2 A G 8: 41,365,554 (GRCm39) T462A probably benign Het
Spsb2 A G 6: 124,786,450 (GRCm39) E61G probably damaging Het
Srr A G 11: 74,803,943 (GRCm39) Y5H probably benign Het
Suclg2 T C 6: 95,546,573 (GRCm39) D301G probably damaging Het
Syt14 A G 1: 192,669,142 (GRCm39) V37A probably benign Het
Syt9 A G 7: 107,035,612 (GRCm39) N210D probably benign Het
Tenm3 T C 8: 48,688,558 (GRCm39) D2343G probably damaging Het
Tma7 A G 9: 108,907,450 (GRCm39) probably benign Het
Tor3a T C 1: 156,497,020 (GRCm39) D175G probably damaging Het
Tpo G T 12: 30,144,964 (GRCm39) A595D possibly damaging Het
Tpst2 T C 5: 112,456,091 (GRCm39) V210A probably damaging Het
Uchl1 A T 5: 66,839,824 (GRCm39) E122V probably benign Het
Vmn1r210 A T 13: 23,011,405 (GRCm39) F294I probably benign Het
Other mutations in Acvrl1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00467:Acvrl1 APN 15 101,041,221 (GRCm39) splice site probably null
IGL00780:Acvrl1 APN 15 101,035,248 (GRCm39) missense probably damaging 1.00
IGL01714:Acvrl1 APN 15 101,035,251 (GRCm39) missense probably damaging 1.00
IGL02962:Acvrl1 APN 15 101,033,382 (GRCm39) missense probably benign 0.00
IGL03341:Acvrl1 APN 15 101,035,477 (GRCm39) missense probably damaging 1.00
R0256:Acvrl1 UTSW 15 101,035,002 (GRCm39) missense probably damaging 1.00
R0538:Acvrl1 UTSW 15 101,034,030 (GRCm39) missense probably damaging 0.99
R1666:Acvrl1 UTSW 15 101,035,458 (GRCm39) missense probably damaging 1.00
R2402:Acvrl1 UTSW 15 101,035,280 (GRCm39) missense probably damaging 1.00
R3789:Acvrl1 UTSW 15 101,035,350 (GRCm39) missense probably damaging 0.98
R4720:Acvrl1 UTSW 15 101,033,654 (GRCm39) missense probably damaging 1.00
R4844:Acvrl1 UTSW 15 101,033,409 (GRCm39) missense probably damaging 0.98
R4995:Acvrl1 UTSW 15 101,033,741 (GRCm39) missense probably benign 0.00
R5053:Acvrl1 UTSW 15 101,035,250 (GRCm39) missense probably damaging 1.00
R5093:Acvrl1 UTSW 15 101,032,628 (GRCm39) splice site probably null
R5191:Acvrl1 UTSW 15 101,034,946 (GRCm39) missense probably damaging 0.99
R6981:Acvrl1 UTSW 15 101,036,226 (GRCm39) missense probably damaging 1.00
R7224:Acvrl1 UTSW 15 101,041,245 (GRCm39) missense probably benign 0.17
R7231:Acvrl1 UTSW 15 101,034,104 (GRCm39) nonsense probably null
R7326:Acvrl1 UTSW 15 101,038,953 (GRCm39) missense probably damaging 0.97
R7555:Acvrl1 UTSW 15 101,041,354 (GRCm39) missense probably benign 0.05
R7569:Acvrl1 UTSW 15 101,033,636 (GRCm39) missense probably benign 0.00
R7627:Acvrl1 UTSW 15 101,033,747 (GRCm39) missense probably benign 0.08
R8971:Acvrl1 UTSW 15 101,033,404 (GRCm39) missense possibly damaging 0.95
R9038:Acvrl1 UTSW 15 101,039,011 (GRCm39) missense possibly damaging 0.82
R9108:Acvrl1 UTSW 15 101,039,038 (GRCm39) missense probably damaging 1.00
R9398:Acvrl1 UTSW 15 101,034,924 (GRCm39) nonsense probably null
Posted On 2016-08-02